Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 21Genitourinary 6Breast 6Thoracic 5Gynecologic 5Gastrointestinal 4Sarcoma 3Lymphoid 3Dermatologic 3CNS 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1NET 1Endocrine 1

Conditions

Obesity 20Mucositis 19Constipation 13Neoplasms 11Opioid-Induced Constipation 9Pain 8Overweight 6Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sexual Dysfunction, Physiological 4Bronchiolitis Obliterans Syndrome 4Xerostomia 3Stomatitis 3Radiation Injuries 3Polycystic Ovary Syndrome 3Endometrial Neoplasms 3Breast Neoplasms 3Sedentary Behavior 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Glucose Intolerance 2Dyspnea 2Chemotherapy-induced Peripheral Neuropathy 2Venous Thromboembolism 1Urinary Incontinence 1Thyroid Diseases 1Stomach Ulcer 1Stomach Neoplasms 1

Interventions

Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Salivary Gland Neoplasms × Other × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡